Q2 2020 13F Holdings Report, New Holdings, Stock Holdings
Signature - Title
Santiago Donoso - CEO Provida
Location
Las Condes, Santiago, Chile
Holdings as of
June 30, 2020
Value $
$1.72B
Num holdings
64
Date filed
12/9/2020, 10:15 AM
Description
Request for Confidential Treatment (8/14/2020): Confidential Treatment Expired on 12/1/2020. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as
of the end of the calendar quarter for which the report is filed, and the total market value. The market value
column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in
accounts.
PROVIDA PENSION FUND ADMINISTRATOR Q2 2020 Portfolio
Sym
Weight
Trade Impact
Company
Class
Shares Change
Activity
Value Change $
Value $
* Price $
Shares
Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
This filing lists securities holdings reported on the form 13F filed on 08-14-2020 pursuant to a request for confidential treatment and for which confidential treatment expired on 12-01-2020.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Elisabeth Bedore
Authorized Signatory
Whippany, New Jersey
12/8/2020
Please note that this 13F Holdings Report filer is affiliated withMetLife Investment Management, LLC and Metropolitan LifeInsurance Company who are also filing 13F Holdings Reports. Eachentity is filing its own 13F Holdings Report because each entity has investment discretion over certain 13(f) securities reported. Allthree 13F Holdings Report filers are under common control of theirultimate parent, MetLife, Inc., who is filing a 13F Notice Report. The 12-1-2020 amendment was misnumbered, should have been 1 not 3; and (ii) this amendment (no. 2) is, in fact, the 2nd time that the 2Q 2020 13F report is being amended, and corrects the prior amendment that was filed on 12-1-2020.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.